Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods
Sarah P. Hammond(Dana-Farber Cancer Institute), Lindsey R. Baden(Brigham and Women's Hospital), Mark A. Poritz(St. Mark's Hospital), Wayne A. Marasco(Dana-Farber Cancer Institute), Rebecca Gelman(Dana-Farber Cancer Institute), Shannon Stock(Dana-Farber Cancer Institute), Lisa S. Gagne(Brigham and Women's Hospital), Francisco M. Marty(Brigham and Women's Hospital)
Cited by 79
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k